Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Ncardia (Group)

Ncardia develops, produces and commercializes highly predictive human cellular assay systems for safety and efficacy testing. The product portfolio encompasses a broad panel of hiPSC derived cryopreserved cardiomyocytes and neurons. In addition, the company delivers the CardioPlateTM product line of quality controlled ready to use assay plates. Using its cell products, Ncardia develops and provides its customers with a broad portfolio of cardiovascular services from safety pharmacology and disease modeling to cardiovascular drug efficacy screening. Ncardia is based in Belgium, The Netherlands, Germany, and the USA. The company is privately held and was established in September 2017 following the merger of Pluriomics and Axiogenesis, two well-known pioneers in the field of stem cell derived cells for safety and toxicology assessment. *

 

Period Start 2017-09-18 merged
Period End 2021-11-16 acq.controlstake
  Group Kiniciti Bio (WCAS invesment platform) (Group)
  Today Kiniciti Bio (WCAS invesment platform) (Group)
  Predecessor Axiogenesis AG
  Successor Kiniciti Bio (WCAS invesment platform) (Group)
Products Industry iPSC technology (induced pluripotent stem cell technology)
  Industry 2 assay, research
Persons Person Fronhoff, Bernd (Axiogenesis 201603 CFO/COO)
  Person 2 Bohlen, Heribert (Axiogenesis 201603 CEO)
     
Region Region Gosselies
  Country Belgium
  Street 47 Rue Adrienne Bolland
  City 6041 Gosselies
    Address record changed: 2024-01-05
     
Basic data Employees C: 51 to 100 (2017-09-18)
     
    * Document for »About Section«: Ncardia. (12/4/17). "Press Release: Ncardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS Cells". Gosselies.
     
   
Record changed: 2024-02-12

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Kiniciti Bio (WCAS invesment platform) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top